drugset / Trial / NCT00109135
A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of an investigational drug that may help individuals to stop smoking.
Timeline
- Start
- 2005-01
- Primary completion
- 2005-06
- Completion
- 2005-06
Outcome
Missed primary endpoint
paper Taranabant 2-8 mg did not improve smoking cessation PMID 20191360 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | taranabant | Unknown | 8 mg | — |
Indications
No indication recorded.